Ultrasound-Triggered Release of 5-Fluorouracil from Soy Lecithin Echogenic Liposomes

Colorectal cancer is the third most diagnosed cancer and the second leading cause of death. The use of 5-fluorouracil (5-FU) has been the major chemotherapeutic treatment for colorectal cancer patients. However, the efficacy of 5-FU is limited by drug resistance, and bone marrow toxicity through hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezekiel, Charles Izuchukwu, Bapolisi, Alain Murhimalika, Walker, Roderick Bryan, Krause, Rui Werner Maçedo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229429/
https://www.ncbi.nlm.nih.gov/pubmed/34205990
http://dx.doi.org/10.3390/pharmaceutics13060821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229429/
https://www.ncbi.nlm.nih.gov/pubmed/34205990
http://dx.doi.org/10.3390/pharmaceutics13060821

Ejemplares similares